Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-11-25

Link:

https://api.zotero.org/groups/2494380/items/N5VYNNUJ?format=atom

Updated:

11/25/2020, 09:12

From feeds:

[sandbox] K4D COVID-19 Resource Hub ยป Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items

Tags:

Authors:

jimwoodhill

Date tagged:

11/25/2020, 16:14

Date published:

11/25/2020, 09:11